Skip to content

Asset Entities ASST Medical Device — Operating Expenses

Other segment segments

Corporate & Other
$9.78M
Asset Management
$3.36M-38.9%

Similar metrics at other companies

Becton, Dickinson and Company logo
BDXTotal Operating Expenses
$4.62B+12.8%
Abbott logo
ABTMedical Devices — Operating Earnings
$1.89B+17.7%
Alamo Group logo
ALGIndustrial Equipment — Operating Expenses
$32.23M+9.9%
Navient logo
NAVIAll Other Segments — Operating Expenses
$34M-35.8%
Ares Management Corporation logo
ARESOther — Operating Expenses
$838.5K+235%
Patrick Industries logo
PATKManufacturing — Operating Expenses
$76.02M+6.7%

Other financials

Income statement

See full
Revenue$2.8M+1,516%
Operating income-$313.1M-7,588%
Net income-$265.9M-6,993%
EPS (diluted)-$4.53-175%

Balance sheet

See full
Cash & equivalents$95.1M+982%
Total debt$3.4M
Total equity$714.8M+3,548%
Total assets$1.1B+21,931%

Cash flow

See full
Operating cash flow-$31.0M-455%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.02B+1,127%
Enterprise value$932M
P/S118.1×

Profitability

See full
Operating margin-6,563%-18,545pp
Net margin-8,022.9%-20,291pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-189.4%+139pp
Debt / equity
Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device — operating expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Asset Entities's medical device — operating expenses?
Asset Entities (ASST) reported medical device — operating expenses of $7.48M in Q1 2026.
What does medical device — operating expenses mean?
This is the sum of all costs incurred to run the day-to-day operations of the business segment, excluding interest and taxes. It provides a comprehensive view of the segment's cost structure and operational burden. Investors use this to calculate the segment's operating margin and overall cost-efficiency.